TORONTO, ON / ACCESSWIRE / June 26, 2020 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a collaboration with Tech Mahindra Ltd, a leading provider of digital transformation, consulting and business re-engineering services, to offer AI-Based Healthcare solutions as a part of suite of post-COVID-19 technology.

The COVID-19 pandemic has brought upon significant disruption to the global economy which has impacted all the major industries and has highlighted the importance of workplace safety. In keeping with the lines of workplace safety, Tech Mahindra is assembling a suite of technologies which will have a relevance in a post-COVID-19 environment from the context of workplace health and safety.

Venugopal Reddy Kandimalla, Senior VP and Global Head, Healthcare & Life Sciences, Tech Mahindra, said, “We at Tech Mahindra launched our TechM NxT platform in 2018 with a theme of innovative collaboration and every vertical therefore drives a TechMNxT strategy. As part of Tech Mahindra Health NxT platform, we are leveraging the power of digital technologies including artificial intelligence and machine learning to augment our virtual health solutions, which will support healthcare providers and organisations to manage COVID-19 pandemic. While innovating in this space, we are also collaborating with partners with niche solutions to enhance our COVID suite of solutions for different markets on a regular basis”

One of the biggest workplace health and safety issue is impairment for both cannabis and alcohol. Predictmedix has developed a proprietary technology which uses multispectral cameras and can be deployed in a workplace setting to screen for both cannabis and alcohol impairment along with screening for COVID-19 symptoms. The technology is to be deployed using a software as a service (“SaaS”) model on a revenue share basis, which will involve an upfront customization fee followed by a monthly license fee based on the volume of screenings. Tech Mahindra and Predictmedix are working closely to incorporate Predictmedix’s impairment detection technology along with it’s COVID-19 solutions into the suite of post COVID-19 technologies to be offered by Tech Mahindra for workplace and safety across the globe. The collaboration is effective as of June 23, 2020.

The current COVID-19 pandemic has really brought upon an increased focus on workplace health and safety and our impairment detection along with COVID-19 symptom screening technologies fit in well with the suite of technologies being assembled by Tech Mahindra“, said Dr. Rahul Kushwah, COO of Predictmedix.

About Tech Mahindra.

Tech Mahindra represents the connected world, offering innovative and customer-centric information technology experiences, enabling Enterprises, Associates, and the Society to Rise™. Tech Mahindra is operational across 90 countries, helping 973 global customers including Fortune 500 companies. As of April 2020, Tech Mahindra is a US$5.2 billion revenue IT company with 125,000+ employees across 90 countries. The company reported earnings of US$614.6 million in 2019.Tech Mahindra’s convergent, digital, design experiences, innovation platforms and reusable assets connect across a number of technologies to deliver tangible business value and experiences to stakeholders. Tech Mahindra is the highest ranked Non-U.S. company in the Forbes Global Digital 100 list (2018) and in the Forbes Fab 50 companies in Asia (2018).

 

Tech Mahindra part of the USD 21 billion Mahindra Group that employs more than 200,000 people in over 100 countries. The Group operates in the key industries that drive economic growth, enjoying a leadership position in tractors, utility vehicles, after-market, information technology and vacation ownership.

Disclaimer: The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.